A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity

Brazilian Journal of Medical and Biological Research

Volumn 38, Issue 6, 2005, Pages 861-868

  Alves, M F ^a   Araujo, M C ^a   Juliano, M A ^a   Oliveira, E M ^b   Krieger, J E ^b   Casarini, D E ^a   Juliano, L ^a   Carmona, Adriana K ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin converting enzyme activity; Fluorometric assay; Human plasma angiotensin converting enzyme; Rat tissue angiotensin converting enzyme

Indexed keywords

2,4 DINITROPHENOL; AMINOBENZOIC ACID; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; LISINOPRIL; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PEPSTATIN; SODIUM CHLORIDE; TOSYLLYSYL CHLOROMETHYL KETONE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; ZINC CHLORIDE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LOCALIZATION; FLUORESCENCE ANALYSIS; HEART; HUMAN; HUMAN EXPERIMENT; HYDROLYSIS; KIDNEY HOMOGENATE; LIVER HOMOGENATE; LUNG; NONHUMAN; NORMAL HUMAN; RAT; SENSITIVITY ANALYSIS; TEMPERATURE DEPENDENCE; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 21644445525     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2005000600007     Document Type: Article

References (33)

1. Skeggs LT, Kahn JR & Shumway NP (1956). Preparation and function of the hypertensin converting enzyme. Journal of Experimental Medicine, 103: 295-299.
2. Yang HYT, Erdös EG & Levin Y (1970). A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochimica et Biophisica Acta, 214: 374-376.
3. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G & Corvol P (1988). Two putative active centers in human angiotensin I-converting enzyme. Proceedings of the National Academy of Sciences, USA, 85: 9386-9390.
4. Bernstein KE, Martin BM, Edwards AS & Bernstein EA (1989). Mouse angiotensin converting enzyme is a protein composed of two homologous domains. Journal of Biological Chemistry, 264: 11945-11951.
5. Lattion AL, Soubrier F, Allegrini J, Hubert C, Corvol P & Alhenc-Gelas F (1989). The testicular transcript of angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Letters, 252: 99-104.
6. Ehlers MRW, Fox EA, Strydom DJ & Riordan JF (1989). Molecular cloning of human testicular angiotensin-converting enzyme: the testis isoenzyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proceedings of the National Academy of Sciences, USA, 86: 7741-7745.
7. Wei L, Alhenc-Gelas F, Soubrier F, Michaud A, Corvol P & Clauser E (1991). Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. Journal of Biological Chemistry, 266: 5540-5546.
8. Beldent V, Michaud A, Wei L, Chauvet MT & Corvol P (1993). Proteolytic release of human anglotensin-converting enzyme. Journal of Biological Chemistry, 268: 26428-26434.
9. Cushman DW & Cheung HS (1971). Concentration of angiotensin-converting enzyme in tissues of rat. Biochimica et Biophisica Acta, 250: 261-265.
10. Mendelsohn FAO, Allen AM, Chai SY, McKinley MJ, Oldfield BJ & Paxinos G (1990). The brain angiotensin system: insights from mapping its components. Trends in Endocrinology and Metabolism, 1: 189-197.
11. Dzau VJ (1987). Implications of local angiotensin production in cardiovascular physiology and pharmacology. American Journal of Cardiology, 59: 59-65.
12. Dzau VJ (1988). Circulating versus local renin angiotensin system I cardiovascular homeostasis. Circulation, 77: 4-13.
13. Cushman DW & Cheung HS (1971). Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochemical Pharmacology, 20: 1637-1648.
14. Holmquist B, Bunning P & Riordan JF (1979). A continuous spectrophotometric assay for angiotensin converting enzyme. Analytical Biochemistry, 95: 540-548.
15. Friedland J & Silverstein E (1976). A sensitive fluorometric assay for serum angiotensin converting enzyme. American Journal of Clinical Pathology, 66: 416-424.
16. Friedland J & Silverstein E (1977). Sensitive fluorometric assay for serum angiotensin converting enzyme with natural substrate angiotensin I. American Journal of Clinical Pathology, 68: 225-228.
17. Carmel A & Yaron A (1978). An intramolecularty quenched fluorescent tripeptide as a fluorogenic substrate of angiotensin I-converting enzyme and a bacterial dipeptidyl carboxypeptidase. European Journal of Biochemistry 87: 265-273.
18. Oliveira EM, Santos RAS & Krieger JE (2000). Standardization of a fluorometric assay for the determination of tissue angiotensin-converting enzyme activity in rats. Brazilian Journal of Medical and Biological Research, 33: 755-764.
19. Meng QC, Balcells E, Dell'Italia L, Durand J & Oparil S (1995). Sensitive method for quantitation of angiotensin-converting enzyme (ACE) activity in tissue. Biochemical Pharmacology, 50: 1490-1498.
20. 14C) Hippuryl-L-histidyl-L-leucine A substrate for the radiochemical assay of angiotensin converting enzyme. Analytical Biochemistry, 84: 272-276.
21. Alhenc-Gelais F, Weare JA, Johnson RL & Erdös EG (1983). Measurement of human converting enzyme level by direct radioimmunoassay. Journal of Laboratory and Clinical Medicine, 101: 83-95.
22. Araujo MC, Melo RL, Del Nery E, Alves MFM, Juliano MA, Casarini DE, Juliano L & Carmona AK (1999). Internally quenched fluorogenic substrates for angiotensin I-converting enzyme. Journal of Hypertension, 17: 665-672.
23. Araujo MC, Melo RL, Cesari MH, Juliano MA, Juliano L & Carmona AK (2000). Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme. Biochemistry, 39: 8519-8525.
24. Juliano MA & Juliano L (1985). Synthesis and kinetic parameters of hydrolysis by trypsin of some acyl-arginyl-p-nitroanilides and peptides containing arginyl-p-nitroanilide. Brazilian Journal of Medical and Biological Research, 18: 435-445.
25. Hirata IY, Boschcov P, Oliveira MCF, Juliano MA, Miranda A, Chagas JR, Tsuboi S, Okada Y & Juliano L (1991). Synthesis of human angiotensinogen (1-17) containing one of the putative glycosylation binding sites and its hydrolysis by human renin and porcine pepsin. International Journal of Peptide and Protein Research, 38: 298-307.
26. Barios K, Gatos D, Rapolos S, Papaphotiu G, Schafer W & Yao WQ (1989). Esterification of partially protected peptide-fragments with resins - utilization of 2-chlorotritylchloride for synthesis of Leu-15-gastrin-I. Tetrahedron Letters, 30: 3947-3950.
27. Ehlers MRW & Riordan JF (1991). Angiotensin-converting enzyme: Zinc and inhibitor binding stoichiometries of the aromatic and testis enzymes. Biochemistry, 30: 7118-7126.
28. Bradford MM (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72: 248-254.
29. Leatherbarrow RJ (1992). Grafit Version 3.0. Erithacus Software Ltd., Staines, UK.
30. Colton T (1974). Statistics in Medicine. Little, Brown & Co., Boston, MA, USA.
31. Cheung HS & Cushman DW (1973). Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca. Biochimica et Biophisica Acta, 293: 451-463.
32. Carvalho K, Nava RA, França MSF, Medeiros MAS, Camarão GC & Juliano L (1999). A liver metallopeptidase which degrades the circulating hypotensive peptide hormone bradykinin and atrial natriuretic peptide. Brazilian Journal of Medical and Biological Research, 32: 51-54.
33. Molina HM, Carmona AK, Kouyoumdjian M & Borges DR (2000). Thimet oligopeptidase EC 3.4.24.15 is a major liver kininase. Life Sciences, 67: 509-520.